[LGND] YoY Quarter Result on 31-Dec-2005 [#Q4]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
31-Mar-2006
Financial Year
2005
Quarter
31-Dec-2005 [#Q4]
Profit Trend
QoQ- 56.66%
YoY- 75.25%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
Revenue 3,940 13,977 12,389 5,770 34,130 49,068 36,943 -31.12%
PBT -1,587 1,034 -73,964 -8,240 4,506 69,963 -94,410 -49.37%
Tax -3,935 -1,535 -234 -2,918 -36,124 5 -56 103.07%
NP 4,503 3,036 -69,627 5,938 141,364 -2,722 -10,997 -
Tax Rate - 148.45% - - 801.69% -0.01% - -
Total Cost -563 10,941 82,016 -168 -107,234 51,790 47,940 -
Ratio Analysis
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
NP Margin 114.29 21.72 -562.01 102.91 414.19 -5.55 -29.77 -
Per Share
31/12/10 31/12/09 31/12/08 31/12/07 31/12/06 31/12/05 31/12/04 CAGR
EPS 0.23 0.16 -4.37 0.36 10.52 -0.22 -0.90 -
EPS Diluted 0.23 0.16 -4.37 0.36 10.52 -0.22 -0.90 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.